Epigallocatechin Gallate Stabilized by Cyclodextrin Inactivates Influenza Virus and Human Coronavirus 229E

被引:7
作者
Matsuura, Ryosuke [1 ]
Kawamura, Arisa [1 ]
Matsumoto, Yasunobu [1 ,2 ]
Iida, Yoshiki [3 ]
Kanayama, Masanori [3 ]
Kurokawa, Masahiko [4 ]
Aida, Yoko [1 ]
机构
[1] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Global Infect Dis Control Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan
[2] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Global Anim Resource Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan
[3] HPG Co Ltd, Chuo Ku, 3-18-9 Hatchobori, Tokyo 10400332, Japan
[4] Kyushu Univ Hlth & Welf, Grad Sch Clin Pharm, 1714-1 Yoshino Cho, Miyazaki 8828508, Japan
关键词
epigallocatechin gallate; cyclodextrin; influenza virus; HCoV-229E; adsorption; inactivation; GREEN TEA POLYPHENOL; REPLICATION;
D O I
10.3390/microorganisms10091796
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Natural products are attractive antiviral agents because they are environment-friendly and mostly harmless. Epigallocatechin gallate (EGCg), a type of catechin, is a well-known natural antiviral agent that can inhibit various viruses. However, EGCg easily oxidizes and loses its physiological activity. Although this problem can be overcome by combining EGCg with cyclodextrin (CD-EGCg), which makes it stable in water at high concentrations, the antiviral effect of this compound remains unclear. Here, we show that in Madin-Darby canine kidney (MDCK) and MRC-5 cells, CD-EGCg is cytotoxic for 50% of cells at 85.61 and 65.34 ppm, respectively. Furthermore, CD-EGCg mainly shows its antiviral effect during the adsorption step for all four influenza virus strains (median effect concentration (EC50) was 0.93 to 2.78 ppm). Its antiviral effect post-adsorption is less intense, and no inhibitory effect is observed on influenza viruses pre-adsorption. Moreover, human coronavirus 229E (HCoV-229E) was inhibited at the adsorption step in short contact (EC50 = 2.5 ppm) and long contact conditions (EC50 = 0.5 ppm) by mixing CD-EGCg with HCoV-229E. These results suggest that CD-EGCg effectively inhibits various viruses that require an adsorption step, and is an effective tool for preventing infection.
引用
收藏
页数:9
相关论文
共 23 条
[11]   UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins [J].
Lo, Chieh-Wen ;
Matsuura, Ryosuke ;
Iimura, Kazuki ;
Wada, Satoshi ;
Shinjo, Atsushi ;
Benno, Yoshimi ;
Nakagawa, Masaru ;
Takei, Masami ;
Aida, Yoko .
SCIENTIFIC REPORTS, 2021, 11 (01)
[12]  
Mamenzigou U.M., 2013, T MAT RES SOC JPN, V38, P681, DOI [10.14723/tmrsj.38.681, DOI 10.14723/TMRSJ.38.681]
[13]   SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein [J].
Matsuura, Ryosuke ;
Lo, Chieh-Wen ;
Wada, Satoshi ;
Somei, Junichi ;
Ochiai, Heihachiro ;
Murakami, Takeharu ;
Saito, Norihito ;
Ogawa, Takayo ;
Shinjo, Atsushi ;
Benno, Yoshimi ;
Nakagawa, Masaru ;
Takei, Masami ;
Aida, Yoko .
VIRUSES-BASEL, 2021, 13 (05)
[14]   INHIBITION OF THE INFECTIVITY OF INFLUENZA-VIRUS BY TEA POLYPHENOLS [J].
NAKAYAMA, M ;
SUZUKI, K ;
TODA, M ;
OKUBO, S ;
HARA, Y ;
SHIMAMURA, T .
ANTIVIRAL RESEARCH, 1993, 21 (04) :289-299
[15]   Epigallocatechin gallate as a nutraceutical to potentially target the metabolic syndrome: novel insights into therapeutic effects beyond its antioxidant and anti-inflammatory properties [J].
Ntamo, Yonela ;
Jack, Babalwa ;
Ziqubu, Khanyisani ;
Mazibuko-Mbeje, Sithandiwe E. ;
Nkambule, Bongani B. ;
Nyambuya, Tawanda M. ;
Mabhida, Sihle E. ;
Hanser, Sidney ;
Orlando, Patrick ;
Tiano, Luca ;
Dludla, Phiwayinkosi, V .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2024, 64 (01) :87-109
[16]   Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins [J].
Ohgitani, Eriko ;
Shin-Ya, Masaharu ;
Ichitani, Masaki ;
Kobayashi, Makoto ;
Takihara, Takanobu ;
Kawamoto, Masaya ;
Kinugasa, Hitoshi ;
Mazda, Osam .
MOLECULES, 2021, 26 (12)
[17]   Cyclodextrins as an encapsulation molecular strategy for volatile organic compounds- Pharmaceutical applications [J].
Paiva-Santos, Ana Claudia ;
Ferreira, Laura ;
Peixoto, Diana ;
Silva, Fernando ;
Saores, Maria Joao ;
Zeinali, Mahdi ;
Zafar, Hajra ;
Mascarenhas-Melo, Filipa ;
Raza, Faisal ;
Mazzola, Priscila Gava ;
Veiga, Francisco .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2022, 218
[18]   Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine [J].
Polack, Fernando P. ;
Thomas, Stephen J. ;
Kitchin, Nicholas ;
Absalon, Judith ;
Gurtman, Alejandra ;
Lockhart, Stephen ;
Perez, John L. ;
Perez Marc, Gonzalo ;
Moreira, Edson D. ;
Zerbini, Cristiano ;
Bailey, Ruth ;
Swanson, Kena A. ;
Roychoudhury, Satrajit ;
Koury, Kenneth ;
Li, Ping ;
Kalina, Warren V. ;
Cooper, David ;
Frenck, Robert W., Jr. ;
Hammitt, Laura L. ;
Tureci, Ozlem ;
Nell, Haylene ;
Schaefer, Axel ;
Unal, Serhat ;
Tresnan, Dina B. ;
Mather, Susan ;
Dormitzer, Philip R. ;
Sahin, Ugur ;
Jansen, Kathrin U. ;
Gruber, William C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) :2603-2615
[19]   A Novel Class of HIV-1 Inhibitors Targeting the Vpr-Induced G2-Arrest in Macrophages by New Yeast- and Cell-Based High-Throughput Screening [J].
Sato, Hirotaka ;
Murakami, Tomoyuki ;
Matsuura, Ryosuke ;
Abe, Masako ;
Matsuoka, Seiji ;
Yashiroda, Yoko ;
Yoshida, Minoru ;
Akari, Hirofumi ;
Nagasawa, Yosuke ;
Takei, Masami ;
Aida, Yoko .
VIRUSES-BASEL, 2022, 14 (06)
[20]  
Sawamura Rie, 2010, Antiviral Chemistry & Chemotherapy, V21, P33, DOI 10.3851/IMP1676